Hans-ulrich Haring

Otfried Müller Str. 10
Tuebingen, BW 72076, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Dissociation of Fatty Liver and Insulin Resistance in I148M PNPLA3 Carriers: Differences in Diacylglycerol (DAG) FA18:1 Lipid Species as a Possible Explanation.

Dissociation of Fatty Liver and Insulin Resistance in I148M PNPLA3 Carriers: Differences in Diacylglycerol (DAG) FA18:1 Lipid Species as a Possible Explanation.

Journal: Nutrients

Published: August 06, 2018

A Vitamin E-Enriched Antioxidant Diet Interferes with the Acute Adaptation of the Liver to Physical Exercise in Mice.

A Vitamin E-Enriched Antioxidant Diet Interferes with the Acute Adaptation of the Liver to Physical Exercise in Mice.

Journal: Nutrients

Published: March 26, 2018

Higher prevalence of lymph node metastasis in prostate cancer in patients with diabetes.

Higher prevalence of lymph node metastasis in prostate cancer in patients with diabetes.

Journal: Endocrine-related cancer

Published: December 20, 2017

Novel phenotypes of prediabetes?

Novel phenotypes of prediabetes?

Journal: Diabetologia

Published: January 27, 2016

Exercise and diabetes: relevance and causes for response variability.

Exercise and diabetes: relevance and causes for response variability.

Journal: Endocrine

Published: September 10, 2015

Ketoacidosis in a non-diabetic woman who was fasting during lactation.

Ketoacidosis in a non-diabetic woman who was fasting during lactation.

Journal: Nutrition journal

Published: May 04, 2015

Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) and proteinuria predict severity of acute kidney injury in Puumala virus infection.

Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) and proteinuria predict severity of acute kidney injury in Puumala virus infection.

Journal: BMC infectious diseases

Published: February 19, 2015

Empagliflozin as add-on to metformin plus sulphonylurea in patients with type 2 diabetes.

Empagliflozin as add-on to metformin plus sulphonylurea in patients with type 2 diabetes.

Journal: Diabetes research and clinical practice

Published: January 20, 2015

Antihyperglycaemic therapies and cancer risk.

Antihyperglycaemic therapies and cancer risk.

Journal: Diabetes & vascular disease research

Published: September 19, 2014

Empagliflozin as add-on to metformin in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial.

Empagliflozin as add-on to metformin in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial.

Journal: Diabetes care

Published: April 12, 2014

Empagliflozin as add-on to metformin plus sulfonylurea in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial.

Empagliflozin as add-on to metformin plus sulfonylurea in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial.

Journal: Diabetes care

Published: August 22, 2013

Insulin-mediated cortical activity in the slow frequency range is diminished in obese mice and promotes physical inactivity.

Insulin-mediated cortical activity in the slow frequency range is diminished in obese mice and promotes physical inactivity.

Journal: Diabetologia

Published: April 07, 2009

Showing 1-12 of 13

Last Updated: 09/26/2026